BCL9


Summary: BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location
OMIM IDMIM:602597
PHARMGKB IDPA25318
Map Location1q21.2

GO terms in BCL9


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IEA GO:0003713 transcription coactivator activity
MF IPI GO:0005515 protein binding
MF IEA GO:0008013 beta-catenin binding
CC TAS GO:0005654 nucleoplasm
CC IDA GO:0005801 cis-Golgi network
CC IDA GO:1990907 beta-catenin-TCF complex
Showing 1 to 6 of 14 rows rows per page

Gene expression in normal tissue: BCL9

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

undefined33Mitosis1DNA replication1Apoptosis regulation1Th17 cell differentiation1IGFR signaling1Other, kinases1One carbon pool by folate1

Pathways in BCL9


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-162582 Signal Transduction
reactome R-HSA-195721 Signaling by WNT
reactome R-HSA-201681 TCF dependent signaling in response to WNT
reactome R-HSA-201722 Formation of the beta-catenin:TCF transactivating complex
reactome R-HSA-3769402 Deactivation of the beta-catenin transactivating complex
pid betacatenin_nuc_pathway Regulation of nuclear beta catenin signaling and target gene transcription
Showing 1 to 6 of 9 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD446 LY 2183240 5
iGMDRD193 Fqi1 2
iGMDRD297 Austocystin D 1
iGMDRD466 Chaetocin 3
Showing 1 to 4 of 40 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in BCL9

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​